| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/29/2005 | US6969524 Interferon complex and medicinal use thereof |
| 11/29/2005 | US6969519 Nucleotide sequences coding membrane protein for use in the treatment of autoimmune, rheumatoid disease, dibates, multiple sclerosis, Sjogren's syndome, glomerulonephritis and myasthenia gravis |
| 11/29/2005 | US6969518 Compositions and methods for the therapy and diagnosis of breast cancer |
| 11/29/2005 | US6969517 Anticancer agents; genetic engineered fusion protein |
| 11/29/2005 | US6969516 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration |
| 11/29/2005 | US6969515 Comprises proteolytic enzymes; free of plasminogen activator |
| 11/29/2005 | US6969514 topically administering hyaluronidase |
| 11/29/2005 | US6969508 Buccal aerosol sprays or capsules using polar and non-polar solvent which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect |
| 11/29/2005 | CA2308532C Use of bisphosphonates for the treatment of osteogenesis imperfecta |
| 11/29/2005 | CA2223960C Reconstituted collagen fiber segment compositions and methods of preparation thereof |
| 11/29/2005 | CA2118329C Isolation, characterization, and use of the human .beta. subunit of the high affinity receptor for immunoglobulin e |
| 11/26/2005 | CA2503105A1 Use of lif in cosmetics and dermatology |
| 11/24/2005 | WO2005111199A1 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 11/24/2005 | WO2005111072A2 Notch-based fusion proteins and uses thereof |
| 11/24/2005 | WO2005111070A2 Mucin3 egf-like domains |
| 11/24/2005 | WO2005111064A1 Cyclopeptide derivatives with anti-integrin activity |
| 11/24/2005 | WO2005111063A1 Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents |
| 11/24/2005 | WO2005110494A2 Methods and compositions for the inhibition of thrombus formation |
| 11/24/2005 | WO2005110478A2 Combination therapy for treating fibrotic disorders |
| 11/24/2005 | WO2005110476A1 Method of inhibiting telomerase activity and inhibitor |
| 11/24/2005 | WO2005110473A2 Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases |
| 11/24/2005 | WO2005110469A2 Methods and compositions for reducing oxalate concentrations |
| 11/24/2005 | WO2005110468A2 Treatment of insulin resistance/metabolic syndrome to alleviate the risks of dementia |
| 11/24/2005 | WO2005110467A1 A composition comprising pyy for the treatment of gastrointestinal disorders |
| 11/24/2005 | WO2005110466A1 Hydrogel interferon formulations |
| 11/24/2005 | WO2005110465A2 Oral formulations comprising bone morphogenetic proteins for treating metabolic bone diseases |
| 11/24/2005 | WO2005110464A2 Irx5 inhibition as treatment for hyperproliferative disorders |
| 11/24/2005 | WO2005110463A1 Methods of inhibiting proinflammatory cytokine expression using ghrelin |
| 11/24/2005 | WO2005110462A2 Methods and compositions for treatment of preeclampsia |
| 11/24/2005 | WO2005110461A2 Leptin peptide antagonists |
| 11/24/2005 | WO2005110460A2 Diagnosis and treatment methods related to aging, especially in muscle (14.1) |
| 11/24/2005 | WO2005110459A2 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 11/24/2005 | WO2005110458A1 Use of sulglicotide for the treatement of mucositis |
| 11/24/2005 | WO2005110457A2 Treatment of eating disorders and induction of lipolysis |
| 11/24/2005 | WO2005110456A2 T-cell death-inducing epitopes |
| 11/24/2005 | WO2005110455A2 Combination therapy for treating hepatitis virus infection |
| 11/24/2005 | WO2005110454A2 Protective binding members of pyy for the treatment of metabolic disorders |
| 11/24/2005 | WO2005110453A2 Cleavage of vegf and vegf receptor by wildtype and mutant mt-sp1 |
| 11/24/2005 | WO2005110451A1 Coffee bean extract, extraction method and composition containing the extract |
| 11/24/2005 | WO2005110450A1 Medicinal composition and therapeutic method |
| 11/24/2005 | WO2005110445A2 Methods and compositions for the dietary management of autoimmune disorders |
| 11/24/2005 | WO2005110425A1 Polymer-based sustained release device |
| 11/24/2005 | WO2005110408A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes |
| 11/24/2005 | WO2005110405A1 Compositions for affecting weight loss |
| 11/24/2005 | WO2005110390A1 Novel use of peptide compounds for treating dyskinesia |
| 11/24/2005 | WO2005110338A2 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | WO2005110056A2 Compositions comprising addl receptor syngap |
| 11/24/2005 | WO2005110046A2 Method of enhancing uptake of keratinocyte growth factor |
| 11/24/2005 | WO2005087253A3 Interferon-beta for anti-virus therapy for respiratory diseases |
| 11/24/2005 | WO2005079844A3 Use for interleukin-33 (il33) and the il-33 receptor complex |
| 11/24/2005 | WO2005076003A3 Diagnostics and therapeutics for diseases associated with plasma glutamate carboxypeptidase (pgcp) |
| 11/24/2005 | WO2005076001A3 A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual |
| 11/24/2005 | WO2005073383A3 HETERODIMERIC FOLLICLE STIMULATING HORMONE-Fc (FSH-Fc) FUSION PROTEINS FOR THE TREATMENT OF INFERTILITY |
| 11/24/2005 | WO2005067965A3 Use of protein products for preventing and treating pancreatic diseases and/or obestiy and/or metabolic syndrome |
| 11/24/2005 | WO2005061539A3 Treatment of viral infections |
| 11/24/2005 | WO2005058958A3 Novel glp-1 analogues linked to albumin-like agents |
| 11/24/2005 | WO2005058358A3 Use of agents derived from ceacam1 for the treatment of inflammatory diseases |
| 11/24/2005 | WO2005049852A3 Methods and compositions for inducing apoptosis |
| 11/24/2005 | WO2005047511A3 Bacterial expression of protease inhibitors and variants thereof |
| 11/24/2005 | WO2005046710A3 Tgf-beta binding and supported peptides |
| 11/24/2005 | WO2005046709A3 Tgf - beta binding and supported peptides |
| 11/24/2005 | WO2005041887A3 Pigment epithelium-derived factor, novel biological activity and methods of use |
| 11/24/2005 | WO2005039498A3 Methods of treating cancer with hdac inhibitors |
| 11/24/2005 | WO2005000246A3 Methods and compositions for treating rheumatoid arthritis |
| 11/24/2005 | WO2004104217A3 Protein kinase c zeta as a drug target for arthritis and other inflammatory diseases |
| 11/24/2005 | WO2004103271A3 Disease prevention and vaccination prior to thymic reactivations |
| 11/24/2005 | WO2004092379A9 Method for treatment of angiogenic disorders |
| 11/24/2005 | WO2002070652A3 Novel molecules of the card-related protein family and uses thereof |
| 11/24/2005 | US20050262577 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 11/24/2005 | US20050261561 Blood testing and therapeutic compound delivery system |
| 11/24/2005 | US20050261495 Lactam Compound |
| 11/24/2005 | US20050261482 Regulation of human serine-threonine protein kinase |
| 11/24/2005 | US20050261478 For activating T and/or B cells by aggregating three or more cell surface antigens; the activation signals may result in either immune enhancement or immunosuppression |
| 11/24/2005 | US20050261477 Pharmaceutical compositions and medical treatments comprising notch ligand proteins |
| 11/24/2005 | US20050261472 Binding moieties for fibrin |
| 11/24/2005 | US20050261338 Beta2-adrenergic receptor agonists |
| 11/24/2005 | US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 11/24/2005 | US20050261265 modulating cellular senescence in vitro by introducing a polynucleotide (gDNA or cDNA) encoding an amphiphysin-1 protein; genetic engineering; genetic disorders, premature aging |
| 11/24/2005 | US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger |
| 11/24/2005 | US20050261230 Method for the prophylaxis and/or treatment of medical disorders |
| 11/24/2005 | US20050261229 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 11/24/2005 | US20050261228 Polynucleotide; diagnosis, therapy of Crohn's disese, encephalomyelitis, antitumor agents; modulate interleukins |
| 11/24/2005 | US20050261225 Peptides that deliver antisense oligonucleotides which downregulate protein expression in cells |
| 11/24/2005 | US20050261224 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 11/24/2005 | US20050261223 Contacting the cell with a small inhibitory RNA (siRNA) that inhibits expression of a RIP140 polypeptide, thereby increasing glucose transport in the cell; eating disoders; metabolism; antidiabetic agents; brown fat |
| 11/24/2005 | US20050261220 Tumor treating combinations, compositions and methods |
| 11/24/2005 | US20050261212 RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering RNA |
| 11/24/2005 | US20050261204 administering to the subject the compound (R)-2-acetamido-N-benzyl-3-methoxypropionamide |
| 11/24/2005 | US20050261203 Azabicyclo-octane inhibitors of IAP |
| 11/24/2005 | US20050261202 Sensitization to another anticancer therapy and/or amelioration of a side effect of another anitcancer therapy by treatment with a GST-activated anticancer compound |
| 11/24/2005 | US20050261201 Method of reducing C-reactive protein using growth hormone secretagogues |
| 11/24/2005 | US20050261200 Inhibiting the replication of hepatitis C virus, therapy, infection |
| 11/24/2005 | US20050261199 Amidated D-Proline, D-Tyrosine, D-Valine, and D-Leucine, D-Threonine, D-Valline; lowering serum triglyceride levels |
| 11/24/2005 | US20050261197 Coffee bean extract, method of extraction and composition containing the same |
| 11/24/2005 | US20050261196 Comprising nonapeptide wherein first three amino acids and last three amino acids of sequence comprise basic amino acids, and wherein inhibitor comprises at least one D-amino acid or at least one non-hydrolyzable bond; may be used to treat intestinal diseases; infectious, ischemic, inflammatory disease |
| 11/24/2005 | US20050261194 Use of thymulin-like peptides for making pain-relieving medicines |
| 11/24/2005 | US20050261193 Antimicrobial theta defensins and methods of using same |
| 11/24/2005 | US20050261192 Novel polypeptide and its DNA |
| 11/24/2005 | US20050261191 neutrophil gelatinase-associated lipocalin (NGAL); siderophore coadministration to enhance secretion |
| 11/24/2005 | US20050261190 Fas associated factor 1 |